Brief: Seegene's Allplex™ SARS CoV-2 FluA/FluB/RSV Assay Approved Under Health Canada's Interim Order
17/01/2022 12:21
Jan 17 (Reuters) - Seegene Inc 096530.KQ :
* SEEGENE'S ALLPLEX™ SARS COV-2 FLUA/FLUB/RSV ASSAY APPROVED
UNDER
HEALTH CANADA'S INTERIM ORDER
Source text for Eikon: ID:nCNWJbd8za
Further company coverage: 096530.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seegene
See all newsBrief: Seegene To Cancel 174 Billion Won Worth Of Own Shares
Brief: Seegene Q4 Operating Profit 7 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Establishes French Subsidiary To Expand European Footprint
Brief: Seegene Q2 Operating Profit 3 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Q1 Operating Profit 14.8 Billion Won, Swings To Profit From Year Earlier